| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Mustang Bio Inc (NASDAQ: MBIO)
MBIO Technical Analysis
5
| As on 3rd Jan 2025 MBIO STOCK Price closed @ 0.22 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.62 & Strong Sell for SHORT-TERM with Stoploss of 3.38 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MBIOSTOCK Price
| Open | 0.23 | Change | Price | % |
| High | 0.25 | 1 Day | 0.01 | 4.76 |
| Low | 0.21 | 1 Week | 0.06 | 37.50 |
| Close | 0.22 | 1 Month | 0.00 | 0.00 |
| Volume | 37249205 | 1 Year | -4.78 | -95.60 |
| 52 Week High 5.20 | 52 Week Low 0.13 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| FCUV | 0.96 | 174.29% |
| NVDA | 144.47 | 4.45% |
| QSI | 4.29 | 0.70% |
| CRNC | 19.33 | 143.76% |
| LMDX | 0.02 | 0.00% |
| CYCC | 0.46 | 24.32% |
| LCID | 3.29 | 8.58% |
| TNXP | 0.31 | 0.00% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| MBIO Daily Charts |
MBIO Intraday Charts |
Whats New @ Bazaartrend |
MBIO Free Analysis |
|
|
MBIO Important Levels Intraday
| RESISTANCE | 0.30 |
| RESISTANCE | 0.27 |
| RESISTANCE | 0.26 |
| RESISTANCE | 0.24 |
| SUPPORT | 0.20 |
| SUPPORT | 0.18 |
| SUPPORT | 0.17 |
| SUPPORT | 0.14 |
MBIO Forecast January 2025
| 4th UP Forecast | 5.56 |
| 3rd UP Forecast | 3.85 |
| 2nd UP Forecast | 2.79 |
| 1st UP Forecast | 1.73 |
| 1st DOWN Forecast | -1.29 |
| 2nd DOWN Forecast | -2.35 |
| 3rd DOWN Forecast | -3.41 |
| 4th DOWN Forecast | -5.12 |
MBIO Weekly Forecast
| 4th UP Forecast | 2.15 |
| 3rd UP Forecast | 1.53 |
| 2nd UP Forecast | 1.15 |
| 1st UP Forecast | 0.77 |
| 1st DOWN Forecast | -0.33 |
| 2nd DOWN Forecast | -0.71 |
| 3rd DOWN Forecast | -1.09 |
| 4th DOWN Forecast | -1.71 |
MBIO Forecast2025
| 4th UP Forecast | 10.51 |
| 3rd UP Forecast | 7.21 |
| 2nd UP Forecast | 5.17 |
| 1st UP Forecast | 3.13 |
| 1st DOWN Forecast | -2.69 |
| 2nd DOWN Forecast | -4.73 |
| 3rd DOWN Forecast | -6.77 |
| 4th DOWN Forecast | -10.07 |
Mustang Bio Inc ( NASDAQ USA Symbol : MBIO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MBIO Business Profile
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-107 and MB-207, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-102 CAR T therapies for blastic plasmacytoid dendritic cell neoplasm, acute myeloid leukemia, and myelodysplastic syndrome; MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-104 CAR T for multiple myeloma and light chain amyloidosis; MB-101 CAR T cell program for glioblastoma; MB-103 CAR T for glioblastoma multiforme (GBM) and metastatic breast cancer to brain; MB-105 CAR T for prostate and pancreatic cancers; and MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital, SIRION Biotech GmbH, and Minaris Regenerative Medicine GmbH. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts. Address: 377 Plantation Street, Worcester, MA, United States, 01605
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service